REGISTERED NUMBER: 10160127 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31st March 2026

for

Altimapa Limited

Page

Balance Sheet

1

FIXED ASSETS

54,526

57,608

CURRENT ASSETS

539,455

513,862

PREPAYMENTS AND ACCRUED INCOME

8,227

12,768

CREDITORS

Amounts falling due within one year

(39,700

)

(18,343

)

NET CURRENT ASSETS

507,982

508,287

TOTAL ASSETS LESS CURRENT LIABILITIES

562,508

565,895

ACCRUALS AND DEFERRED INCOME

(13,455

)

(6,997

)

NET ASSETS

549,053

558,898

CAPITAL AND RESERVES

549,053

558,898

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Altimapa Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

10160127

Registered office:

15 Hanover Square

London

Greater London

W1S 1HS

The presentation currency of the financial statements is the Pound Sterling (£).

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2025 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 9th October 2026 and were signed by:

Dr. P Tavares - Director